Perceptive Advisors - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 104 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 1.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$79,208,000
-18.4%
2,259,224
-50.0%
1.15%
+82.7%
Q2 2021$97,056,000
-47.5%
4,518,448
+45.3%
0.63%
-73.0%
Q1 2021$184,693,000
+42.2%
3,109,2240.0%2.34%
+67.6%
Q4 2020$129,903,0003,109,2241.39%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 1,265,631$27,186,00091.01%
Yu Fan 143,867$3,090,00034.92%
AJU IB Investment Co., Ltd. 1,745,331$37,490,00021.62%
Bain Capital Life Sciences Investors, LLC 5,615,659$120,624,0007.90%
Cormorant Asset Management, LP 6,411,355$137,716,0004.68%
Ally Bridge Group (NY) LLC 373,288$8,018,0001.99%
RA Capital Management 5,368,451$115,314,0001.85%
Omega Fund Management, LLC 746,868$16,043,0001.82%
CM Management, LLC 90,000$1,933,0001.40%
SECTORAL ASSET MANAGEMENT INC 538,884$11,575,0000.94%
View complete list of ATEA PHARMACEUTICALS INC shareholders